Nanosonics Limited (NNCSF)
NNCSF Stock Price Chart
Explore Nanosonics Limited interactive price chart. Choose custom timeframes to analyze NNCSF price movements and trends.
NNCSF Company Profile
Discover essential business fundamentals and corporate details for Nanosonics Limited (NNCSF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
13 Aug 2012
Employees
466.00
Website
https://www.nanosonics.com.auCEO
Michael C. Kavanagh BSc,
Description
Nanosonics Limited, together with its subsidiaries, operates as an infection prevention company in Australia and internationally. The company engages in the manufacturing and distribution of the trophon ultrasound probe disinfector, and its associated consumables and accessories; and research, development, and commercialization of infection control and decontamination products and related technologies. It provides trophon2, an ultrasound probe high level disinfection device; trophon EPR, a low temperature high level disinfection solution for intra-cavity ultrasound probes; and Nanosonics AuditPro, an infection control workflow compliance management solution. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
NNCSF Financial Timeline
Browse a chronological timeline of Nanosonics Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Feb 2026
Earnings released on 26 Aug 2025
EPS came in at $0.02 surpassing the estimated $0.02 by +0.30%, while revenue for the quarter reached $64.85M , beating expectations by +0.33%.
Earnings released on 19 Feb 2025
EPS came in at $0.02 surpassing the estimated $0.01 by +46.66%, while revenue for the quarter reached $57.91M , beating expectations by +1.92%.
Earnings released on 26 Aug 2024
EPS came in at $0.01 surpassing the estimated $0.01 by +27.19%, while revenue for the quarter reached $59.58M , missing expectations by -1.31%.
Earnings released on 26 Feb 2024
EPS came in at $0.01 surpassing the estimated $0.01 by +51.32%, while revenue for the quarter reached $54.91M , beating expectations by +1.32%.
Earnings released on 30 Jun 2023
EPS came in at $0.02 surpassing the estimated $0.01 by +54.28%, while revenue for the quarter reached $56.93M , missing expectations by -1.07%.
Earnings released on 31 Dec 2022
EPS came in at $0.02 surpassing the estimated $0.02 by +12.62%, while revenue for the quarter reached $55.90M , beating expectations by +0.50%.
Earnings released on 30 Jun 2022
EPS came in at -$0.00 surpassing the estimated -$0.01 by +97.83%, while revenue for the quarter reached $41.52M , beating expectations by +1.29%.
Earnings released on 31 Dec 2021
EPS came in at $0.01 surpassing the estimated $0.01 by +23.66%, while revenue for the quarter reached $43.01M , beating expectations by +2.63%.
Earnings released on 30 Jun 2021
EPS came in at $0.02 surpassing the estimated $0.01 by +191.18%, while revenue for the quarter reached $44.06M , beating expectations by +6.18%.
Earnings released on 31 Dec 2020
EPS came in at $0.00 falling short of the estimated $0.01 by -71.88%, while revenue for the quarter reached $33.09M , missing expectations by -16.80%.
NNCSF Stock Performance
Access detailed NNCSF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.